North America Cannabis Market

Focus on Application, Derivative, and Region – Estimation & Forecast, 2015-2020

Published Year: 2015
SKU: EC00338SA
View TOC Request Sample

1000

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Report Description

Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative products and their uses, its applic

Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp.

The size of the market for cannabis implies that market participants are more varied. Thus, the company profile section has been broken down into different types of market participants: producers, information technology, funding & finance, equipment & infrastructure, research & development, advisory services & education, branding, sales & marketing, and retail & dispensary.
Read More

Scope of the Research Study

The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp

The following pointers will encompass the scope of the research study and will lend a better understanding to the reader.

• The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp
• The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized
• Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014)
• The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state’s revenue are clubbed as others
• Through the forecast period, the ‘other’ states segment will also include the revenue from further states that are anticipated to legalize medical marijuana
• The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity
• The report includes the estimates of different entities of the cannabis ecosystem
• The report also includes the optimistic revenue estimate for the benchmark year only for the U.S
• Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included
Read More

Market Overview

Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative products and their uses, its applic

Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative products and their uses, its applications and wide acceptance. Owing to the medicinal and industrial uses of the cannabis plant, cannabis market is growing rapidly. Factors like multi-faceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others.

The U.S. state California generates the maximum revenue $1.15 billion in the marijuana market among all the states in the U.S. while Oregon and Rhode Island will be growing at the fastest CAGR of 36.10% and 36.93% respectively. If the industry keeps on growing with the same pace, it will spread to all the 50 states of the U.S.
Read More

Table of Contents

Request a Sample

RESEARCH METHODOLOLOGY, SCOPE AND COVERAGE

1.1 Scope Of The Study
1.2 Research Methodology
1.2.1 Overall Market Estimation And Forecast
1.2.2 Bis Research Methodology
1.3 Report Description

EXECUTIVE SUMMARY

2.1 EXECUTIVE SUMMARY

INTRODUCTION TO NORTH AMERICAN CANNABIS MARKET

3.1 Cannabis Market Evolution And Trend
3.2 The Cannabis Ecosystem In North America: Estimate And Forecast
3.3 The Optimistic Estimate For The U.S. Mrijuana Market
3.4 Tax Revenue Estimation For The U.S. Marijuana Market

KEY STRATEGIES AND DEVELOPMENT IN THE NORTH AMERICAN CANNABIS MARKET (2013-2015)

4.1 Introduction
4.2 Mergers And Acquisitions
4.3 Partnership, Collaboration & Joint Ventures
4.4 Product Launch
4.5 Business Expansion
4.6 Product Testing
4.7 Others

MARKET DYNAMICS

5.1 Introduction
5.2 Market Drivers
5.2.1 Automation Transforming The Cannabis Industry
5.2.1.1 Collaboration Of The Vending And Cannabis Industry
5.2.1.2 Automated Irrigation Systems And Fertigation
5.2.2 Increasing Adoption Of Information Technology In The Cannabis Industry
5.2.3 Rapid Adoption Of Cannabis For Medical Purposes
5.2.4 Multi-Faceted Applications Of Cannabis Derivatives
5.2.5 The Profitable Integration Of The Hydroponics And Cannabis Industry
5.2.6 The Combined Effect Of Vaper's Preference For Cannabis Oil And Increasing Adoption Of E-Cigarette
5.3 Market Challenges
5.3.1 Highly Volatile Regulatory Framework
5.3.2 Absence Of Market Leaders And Standards
5.3.3 The Issues Of Perception (Reputation Of Marijuana)/Marijuana Stigma
5.3.4 Federal Level Challenges
5.3.4.1 Lack Of Availability Of Bank Loans To Set Up Operations Due To Federal Banking Prerequisites
5.3.4.2 Federal Ban On Growing Industrial Hemp Forcing The Market Players To Import Raw Hemp
5.3.5 Highly Fragmented Supply Chain
5.3.6 Environmental Hazards

NORTH AMERICA CANNABIS INDUSTRY ANALYSIS

6.1 Porter’s Five Forces Analysis
6.1.1 Threat Of New Entrants
6.1.1.1 Entry Barriers (Government Policy And Capital Requirements)
6.1.1.2 Access To Distribution Channels
6.1.1.3 Economies Of Scale
6.1.1.4 Product Differentiation
6.1.2 Bargaining Power Of Buyers
6.1.2.1 Concentration Of Buyers
6.1.2.2 Importance Of Volume To Buyers
6.1.2.3 Threat Of Backward Integration
6.1.2.4 Buyer’s Information About Supplier’s Product
6.1.2.5 The Existence Of Black Market
6.1.2.6 Switching Cost
6.1.2.7 Legal And Regulatory Framework
6.1.2.8 Presence Of Substitutes
6.1.3 Bargaining Power Of Suppliers
6.1.3.1 Supplier Concentration
6.1.3.2 Threat Of Forward Integration
6.1.3.3 Product Differentiation
6.1.3.4 Switching Cost
6.1.4 Threat from substitutes
6.1.4.1 Buyer’s Propensity Towards Substitute
6.1.4.2 Consumer’s Switching Cost
6.1.5 Intensity Of Competitive Rivalry
6.1.5.1 Customer’s Loyalty Towards Brand
6.1.5.2 Intermittent Over Capacity
6.1.5.3 Product Differentiation
6.1.5.4 Industry Concentration
6.1.5.5 Entry Barriers
6.1.5.6 Exit Barriers
6.2 Value Chain Analysis
6.2.1 Introduction
6.2.2 Cannabis Growers/Producers
6.2.3 Pharmaceutical Companies
6.2.3.1 Research Facilities
6.2.4 Processing Industries
6.2.5 Packaging Industries
6.2.6 Dispensaries
6.2.6.1 Retail
6.2.6.2 Medical
6.2.6.3 Retail Outlets

REGULATORY & LEGAL FRAMEWORK, CONSORTIUMS AND COMPLIANCES

7.1 Introduction
7.2 Regulatory Bodies
7.2.1 Health Canada- Marijuana For Medical Purposes Regulations (MMPR)
7.2.2 Council On Responsible Cannabis Regulation (CRCR)
7.2.3 National Organization For The Reform Of Marijuana Laws (NORML)
7.3 Legal Framework
7.3.1 Federal Marijuana Law- Controlled Substance Act (CSA)
7.3.2 Marijuana Control Act 2014
7.3.3 Hemp Farming Act 2015
7.4 Compliances
7.4.1 Massachusetts Marijuana Compliance
7.4.2 Marijuana Enforcement Tracking Reporting Compliance (METRC)
7.5 Consortiums
7.5.1 American Herbal Products Association (AHPA)
7.5.2 Association Of Responsible Cannabis Public Companies (ARCPC)
7.5.3 Hemp Industries Association (HIA)
7.5.4 Drug Policy Alliance
7.5.5 International Association For Cannabinoid Medicine (IACM)
7.5.6 National Cannabis Industry Association (NCIA)
7.5.7 Canadian Medical Cannabis Industry Association (CMCIA)
7.5.8 California Cannabis Industry Association (CCIA)
7.5.9 Illinois Cannabis Industry Association
7.5.10 North American Industrial Hemp Council Inc. (NAIHC)
7.5.11 Canadian Hemp Trade Alliance (CHTA)
7.5.12 Kentucky Hemp Industries Association(KYHIA)

MARKET SIZING – ESTIMATION, ANALYSIS & FORECAST BY DERIVATIVE

8.1 Introduction
8.1.1 Market Statistics
8.1.2 Marijuana/Flowers
8.1.2.1 Market Statistics
8.1.2.2 Key Players
8.1.3 Industrial Hemp
8.1.3.1 Market Statistics
8.1.3.2 Key Players
8.1.4 Other Concentrates/Products
8.1.4.1 Kief
8.1.4.2 Hash
8.1.4.3 Hash Oil
8.1.4.4 Tinctures
8.1.4.5 Infusions

MARKET SIZING- ESTIMATION, ANALYSIS & FORECAST BY APPLICATION

9.1 Introduction
9.1.1 Market Statistics
9.2 Applications Of Marijuana
9.2.1 Medicinal Applications
9.2.1.1 Market Statistics
9.2.1.2 Key Players
9.2.2 Recreational Application Of Marijuana
9.2.2.1 Market Statistics
9.3 Applications Of Industrial Hemp
9.3.1 Food And Baby Care
9.3.1.1 Market Statistics
9.3.2 Clothing & Textile
9.3.2.1 Market Statistics
9.3.3 Other Hemp Products
9.3.3.1 Market Statistics

MARKET SIZING ANALYSIS & FORECAST, BY MARKET DEMAND

10.1 Introduction
10.1.1 Market Statistics
10.2 The U.S.
10.2.1 Market Statistics
10.2.2 California
10.2.3 Colorado
10.2.4 Washington
10.2.5 Arizona
10.2.6 Michigan
10.2.7 Oregon
10.2.8 Others
10.2.9 Legal & Regulatory Framework
10.2.9.1 Marijuana
10.2.9.2 Industrial Hemp
10.2.10 Key Market Players
10.3 Canada
10.3.1 Market Statistics
10.3.2 Key Market Players

KEY MARKET PLAYERS PROFILE

11.1 Growers
11.1.1 Canadian Cannabis Corporation
11.1.1.1 Company Overview
11.1.1.2 Financials
11.1.1.2.1 Overall Financials
11.1.1.2.2 Financial Summary
11.1.1.3 Key Developments
11.1.2 Plandai Biotechnology
11.1.2.1 Company Overview
11.1.2.2 Financials
11.1.2.2.1 Overall Financials
11.1.2.2.2 Financial Summary
11.1.2.3 Key Developments
11.1.3 Tweed Marijuana Inc.
11.1.3.1 Company Overview
11.1.3.2 Financials
11.1.3.2.1 Overall Financials
11.1.3.2.2 Financial Summary
11.1.3.3 Key Developments
11.1.4 Affinor Growers
11.1.4.1 Company Overview
11.1.4.2 Financials
11.1.4.2.1 Overall Financials
11.1.4.2.2 Financial Summary
11.1.4.3 Key Developments
11.2 Producers
11.2.1 Cannabis Sativa Inc.
11.2.1.1 Company Overview
11.2.1.2 Financials
11.2.1.2.1 Overall Financials
11.2.1.2.2 Financial Summary
11.2.1.3 Key Developments
11.2.2 Cannavest
11.2.2.1 Company Overview
11.2.2.2 Financials
11.2.2.2.1 Overall Financials
11.2.2.2.2 Financial Summary
11.2.2.3 Key Developments
11.2.3 Canna Brands Inc.
11.2.3.1 Company Overview
11.2.3.2 Financial Summary
11.2.3.3 Key Developments
11.2.4 Omnicanna Health Solutions
11.2.4.1 Company Overview
11.2.4.2 Financial Summary
11.2.4.3 Key Developments
11.2.5 Privateer Holdings, Inc.
11.2.5.1 Company Overview
11.2.5.2 Key Developments
11.3 Pharmaceutical & Research Companies
11.3.1 Arena Pharmaceuticals, Inc.
11.3.1.1 Company Overview
11.3.1.2 Financials
11.3.1.2.1 Overall Financials
11.3.1.2.2 Financial Summary
11.3.1.3 Key Developments
11.3.2 Cannabics Pharmaceuticals Inc.
11.3.2.1 Company Overview
11.3.2.2 Financial Summary
11.3.2.3 Key Developments
11.3.3 Cannabis Science, Inc.
11.3.3.1 Company Overview
11.3.3.2 Financials
11.3.3.2.1 Overall Financials
11.3.3.2.2 Financial Summary
11.3.3.3 Key Developments
11.3.4 GW Pharmaceuticals
11.3.4.1 Company Overview
11.3.4.2 Financials
11.3.4.2.1 Overall Financials
11.3.4.2.2 Revenue By Segment
11.3.4.2.3 Revenue By Region
11.3.4.2.4 Financial Summary
11.3.4.3 Key Developments
11.3.5 Hemp, Inc.
11.3.5.1 Company Overview
11.3.5.2 Financials
11.3.5.2.1 Overall Financials
11.3.5.2.2 Financial Summary
11.3.5.3 Key Developments
11.3.6 Insys Therapeutics
11.3.6.1 Company Overview
11.3.6.2 Financials
11.3.6.2.1 Overall Financials
11.3.6.2.2 Revenue By Segment
11.3.6.2.3 Financial Summary
11.3.6.3 Key Developments
11.3.7 Medical Marijuana Inc.
11.3.7.1 Company Overview
11.3.7.2 Financials
11.3.7.2.1 Overall Financials
11.3.7.2.2 Financial Summary
11.3.7.3 Key Developments
11.3.8 22nd Century Group, Inc.
11.3.8.1 Company Overview
11.3.8.2 Financials
11.3.8.2.1 Overall Financials
11.3.8.2.2 Financial Summary
11.3.8.3 Key Developments
11.3.9 Otsuka Pharmaceutical Co. Ltd
11.3.9.1 Company Overview
11.3.9.2 Financials
11.3.9.2.1 Overall Financials
11.3.9.2.2 Revenue By Segment
11.3.9.2.3 Revenue By Region
11.3.9.2.4 Financial Summary
11.3.9.3 Key Developments
11.3.10 Sanofi Pharmaceuticals
11.3.10.1 Company Overview
11.3.10.2 Financials
11.3.10.2.1 Overall Financials
11.3.10.2.2 Financial Summary
11.4 Information Technology
11.4.1 Agrisoft Development Group
11.4.1.1 Company Overview
11.4.1.2 Key Developments
11.4.2 Endexx Corporation
11.4.2.1 Company Overview
11.4.2.2 Financials
11.4.2.2.1 Overall Financials
11.4.2.3 Key Developments
11.4.3 Green Technology Solutions Inc. (GTSO)
11.4.3.1 Company Overview
11.4.3.2 Financials
11.4.3.2.1 Overall Financials
11.4.3.2.2 Financial Summary
11.4.3.3 Key Developments
11.4.4 Quantum 9
11.4.4.1 Company Overview
11.4.4.2 Financials
11.4.4.3 Key Developments
11.5 Equipment & Infrastructure
11.5.1 Advanced Cannabis Solutions
11.5.1.1 Company Overview
11.5.1.2 Financials
11.5.1.2.1 Overall Financials
11.5.1.2.2 Revenue By Segment
11.5.1.2.3 Financial Summary
11.5.1.3 Key Developments
11.5.2 Medbox, Inc.
11.5.2.1 Company Overview
11.5.2.2 Financials
11.5.2.2.1 Overall financials
11.5.2.2.2 Financial Summary
11.5.2.3 Key Developments
11.5.3 Surna, Inc.
11.5.3.1 Company Overview
11.5.3.2 Financials
11.5.3.2.1 Overall Financials
11.5.3.2.2 Financial Summary
11.5.3.3 Key Developments
11.6 Advisory Services And Education
11.6.1 Canna Grow Holdings
11.6.1.1 Company Overview
11.6.1.2 Financials
11.6.1.2.1 Overall Financials
11.6.1.2.2 Financial Summary
11.6.1.3 Key Developments
11.7 Others
11.7.1 Abattis Bioceuticals Corporation
11.7.1.1 Company Overview
11.7.1.2 Financials
11.7.1.2.1 Overall Financials
11.7.1.2.2 Financial Summary
11.7.1.3 Key Developments
11.7.2 Cannabis Therapy Corporation
11.7.2.1 Company Overview
11.7.2.2 Financials
11.7.2.2.1 Overall Financials
11.7.2.2.2 Financial Summary
11.7.2.3 Key Developments
11.7.3 Cannacare Docs
11.7.3.1 Company Overview
11.8 Application (APPS) Companies
11.8.1 Mass Roots
11.8.1.1 Company Overview
11.8.2 Eaze
11.8.2.1 Company Overview
11.8.2.2 Key Developments
11.8.3 Weedmaps
11.8.3.1 Company Overview
11.8.4 Meadow
11.8.4.1 Company Overview
11.8.4.2 Key Developments
11.8.5 Nestdrop
11.8.5.1 Company Overview
11.8.5.2 Key Developments
11.8.6 Leafly
11.8.6.1 Company Overview
11.8.7 Grassp
11.8.7.1 Company Overview
11.8.8 Dave
11.8.8.1 Company Overview
11.8.9 Frweed Pro
11.8.9.1 Company Overview

LIST OF TABLES

TABLE 1 TIMELINE OF MEDICAL MARIJUANA LEGALIZATION
TABLE 2 THE CANNABIS ECOSYSTEM IN NORTH AMERICA REVENUE SPLIT ($BILLION), 2015-2020
TABLE 3 FULL LEGALIZATION OF MARIJUANA ACROSS THE U.S. AND ASSOCIATED TAX REVENUE ESTIMATE
TABLE 4 COMPARISON OF GROWING MARIJUANA IN SOIL-BASED AND SOIL-LESS MEDIUM
TABLE 5 CANNABIS SATIVA VS CANNABIS INDICA
TABLE 6 NORTH AMERICA CANNABIS DERIVATIVE MARKET VALUE ($MILLION), 2015-2020
TABLE 7 NORTH AMERICA MARIJUANA MARKET VALUE($MILLION), BY APPLICATION, 2015-2020
TABLE 8 NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
TABLE 9 NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 10 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 11 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY DISTRIBUTIONMODE, 2015-2020
TABLE 12 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($ MILLION), BY GEOGRAPHY, 2015-2020
TABLE 13 NORTH AMERICA CANNABIS APPLICATION MARKET VALUE ($MILLION), 2015-2020
TABLE 14 DISEASES & CURE BY CANNABIS
TABLE 15 INFORMATION ABOUT KEY MEDICINAL MARIJUANA DRUGS IN NORTH AMERICA
TABLE 16 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
TABLE 17 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 18 NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 19 NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 20 NORTH AMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 21 NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATION MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 22 NORTH AMERICA CANNABIS MARKET BY REGION ($ MILLION), 2015-2020
TABLE 23 THE U.S CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 24 THE U.S. CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 25 THE U.S. MARIJUANA MARKET VALUE ($MILLION), BY KEY STATES, 2015-2020
TABLE 26 MARIJUANA LEGALIZATION DETAILS BY STATES
TABLE 27 MARIJUANA POSESSION DETAILS
TABLE 28 INDUSTRIAL HEMP POSESSION DETAILS
TABLE 29 CANADA CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 30 CANADA CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020

LIST OF FIGURES

FIGURE 1 BIS RESEARCH METHODOLOGY
FIGURE 2 THE EUROPE E-LIQUID MARKET-RESEARCH METHODOLOGY
FIGURE 3 CANNABIS COMPARISON BY DERIVATIVE ($MILLION) 2015-2020
FIGURE 4 CANNABIS COMPARISON BY APPLICATION ($ MILLION) 2014-2020
FIGURE 5 CANNABIS COMPARISON BY GEOGRAPHY ($ MILLION) 2014-2020
FIGURE 6 THE CANNABIS ECOSYSTEM WITH KEY PLAYERS
FIGURE 7 AN OPTIMISTIC ESTIMATE FOR U.S. MARIJUANA MARKET (2014)
FIGURE 8 KEY MERGERS & ACQUISITIONS (2013-15)
FIGURE 9 KEY PARTNERSHIPS & COLLABORATIONS (2013-15)
FIGURE 10 KEY PRODUCT LAUNCHES (2013-15)
FIGURE 11 KEY BUSINESS EXPANSION ACTIVITIES (2013-15)
FIGURE 12 KEY PRODUCT TESTING ACTIVITIES (2013-15)
FIGURE 13 OTHER KEY DEVELOPMENTS (2013-15)
FIGURE 14 BENEFITS OF USING CANNABIS VENDING MACHINES
FIGURE 15 WHY CANNABIS INDUSTRY NEEDS STANDARDS
FIGURE 16 NORTH AMERICA CANNABIS INDUSTRY ANALYSIS-PORTER’S FIVE FORCES
FIGURE 17 NORTH AMERICA CANNABIS MARKET VALUE CHAIN ANALYSIS
FIGURE 18 FEATURE OF MMPR
FIGURE 19 MISSION OF CRCR
FIGURE 20 MISSION OF NORML
FIGURE 21 PROPOSED BEST PRACTICES FOR REGULATION OF CANNABIS GROWING BY AHPA
FIGURE 22 ARCPC MISSION
FIGURE 23 HIA MISSION
FIGURE 24 DPA MISSION
FIGURE 25 STEPS TAKEN BY IACM IN THE CANNABIS INDUSTRY
FIGURE 26 KEY FEATURES OF NCIA
FIGURE 27 CMCIA MISSION
FIGURE 28 NAIHC MISSION
FIGURE 29 KEY VARIETIES OF CANNABIS STRAINS
FIGURE 30 THE PSYCHOACTIVE EFFECTS OF MARIJUANA
FIGURE 31 MEDICAL BENEFITS OF MARIJUANA
FIGURE 32 INDUSTRIES BENEFITING FROM INDUSTRIAL HEMP
FIGURE 33 APPLICATIONS OF CANNABIS PLANT
FIGURE 34 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 35 NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 36 APPLICATIONS OF INDUSTRIAL HEMP
FIGURE 37 NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 38 NORTHAMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 39 NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATIONS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 40 LEGALIZATION STATUS OF CANNABIS
FIGURE 41 CANADIAN CANNABIS CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 42 PLANDAI BIOTECH OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 43 TWEED MARIJUANA OVERALL FINANCIALS, 2013-15 ($ MILLION)
FIGURE 44 AFFINOR GROWERS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 45 CANNABIS SATIVA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 46 CANNAVEST OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 47 ARENA PHARMACEUTICALS OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 48 CANNABIS SCIENCE, INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 49 GW PHARMACEUTICALS; OVERALL FINANCIALS 2012-14 ($MILLION)
FIGURE 50 REVENUE BY SEGMENT 2012-14
FIGURE 51 REVENUE BY REGION2012-2014
FIGURE 52 HEMP INC. OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 53 INSYS THERAPEUTICS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 54 MEDICAL MARIJUANA INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 55 22ND CENTURY GROUP OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 56 OTSUKA OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 57 SANOFIPHARMA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 58 ENDEXX CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 59 GREEN TECHNOLOGY SOLUTIONS; OVERALL FINANCIALS, 2012-2015 ($ MILLION)
FIGURE 60 ADVANCED CANNABIS SOLUTIONS OVERALL FINANCIALS, 2013-2014 ($ MILLION)
FIGURE 61 MEDBOX OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 62 SURNA INC. OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 63 CANNAGROW OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 64 ABATTIS BIOCEUTICALS OVERALL FINANCIALS 2013-14 ($MILLION)
FIGURE 65 CANNABIS THERAPY CORP. OVERALL FINANCIALS, 2014-15 ($MILLION)

North America Cannabis Market

Focus on Application, Derivative, and Region – Estimation & Forecast, 2015-2020

Contact Us

Request a Sample Schedule a Call